Date: 4.2.2019
The wonder-material graphene could hold the key to unlocking the next generation of advanced, early stage lung cancer diagnosis.
A team of scientists from the University of Exeter has developed a new technique that could create a highly sensitive graphene biosensor with the capability to detect molecules of the most common lung cancer biomarkers.
The new biosensor design could revolutionise existing electronic nose (e-nose) devices, that identify specific components of a specific vapour mixture – for example a person's breath – and analyses its chemical make-up to identify the cause.
The research team believe the newly developed device displays the potential to identify specific lung cancer markers at the earliest possible stage, in a convenient and reusable way - making it both cost-effective and highly beneficial for health service providers worldwide.
Using multi-layered graphene, the team suggest that current e-nose devices—which combine electronic sensors with mechanisms for pattern recognition, such as a neural network—could revolutionise breath diagnostic techniques.
Using patterned multi-layered graphene electrodes, the team were able to show greater sensing capabilities for three of the most common lung-cancer biomarkers—ethanol, isopropanol and acetone—across a range of different concentrations.
The team believe this could be the first step towards creating new, improved and cheaper e-nose devices that could give the earliest possible lung-cancer diagnosis.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotech Jobs - Biotechnology jobs at bio.com
Biotechnology links - Useful biotech links for you
More than 100 magic mushroom genomes point the way to new cultivars
Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants